What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Engineering for higher avidity and multi-valency Following chairperson’s remarks from Bruce Keyt, PhD, CSO, R&D, IGM Biosciences, there will be three presentations in this session. Sara Majocchi, PhD, Discovery Program Leader, Light Chain Bioscience – Novimmune SA, on: ‘Bispecific antibody mediated, PD-L1-dependant, CD28 co-stimulation’.
52 
Let's personalize your content